Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1701 Combine With Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT07478731Phase 2Recruiting
- Sponsor
- Conifer Life Sciences
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of retlirafusp alfa in rectal adenocarcinoma, sponsored by Conifer Life Sciences. Started Dec 2025; status: recruiting.
02
Drugs
retlirafusp alfa
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT07478731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07478731.